Phibro Animal Health Shares Jump 11% to $48.66 High After EPS Beat
Phibro Animal Health shares surged nearly 11% to a new 12-month high of $48.66 after reporting fourth-quarter fiscal 2026 EPS of $0.87, topping consensus estimates. The stock holds a Zacks Rank #2 with a VGM Score of A and Momentum Score of B, rising 25.9% over four weeks.
1. Earnings Beat and Stock Reaction
Phibro Animal Health announced fourth-quarter fiscal 2026 adjusted EPS of $0.87, exceeding consensus forecasts. Shares traded up to $48.66, marking a new 12-month high and representing a nearly 11% intraday gain on volume of over 139,000 shares.
2. Zacks Ranking and Style Scores
The stock carries a Zacks Rank #2 (Buy) and a VGM Score of A, combining value, growth, and momentum indicators. Its Momentum Style Score of B reflects strong short-term price trends driven by upward earnings revisions.
3. Short-Term Performance Trends
Phibro’s shares have climbed 25.9% over the past four weeks, outpacing industry and market benchmarks. Recent analyst estimate upgrades have lifted the consensus EPS forecast for fiscal 2026 to $2.83.
4. Analyst Revisions and Outlook
One analyst increased their EPS projection by $0.07 in the last 60 days, signaling confidence in the company’s growth trajectory. Continued product demand in poultry, swine, beef, dairy and specialty segments underpins positive sentiment among investors.